AIIMS: Covid-19 pandemic yet to peak in India

“According to modeling data and the way our cases are increasing, it is likely that peak can come in June and July warned director of All India Institute Medical Sciences (AIIMS) regarding Covid-19 pandemic in the country.

Dr Randeep Guleria, AIIMS Director, further said that, “there are many variables and with time only we will know how much they are effective and the effect of extending the lockdown.”

Since the vaccine is not in the market right now and the research is being conducted, the government is trying to break the chain against Covid-19.

On Thursday, after 43 days since the lockdown began – the number of Covid-19 cases in India has almost touched 53,000 with about 1,800 casualties on. Maharashtra on top with almost 17,000 cases, Gujarat with more than 6,500 cases and Delhi with more than 5,500 cases are the top three states accounting for more than half of India’s total Covid-19 cases.

  • Related Posts

    IPC releases draft NFI-2026 to promote rational use of medicines

    Ghaziabad:- The Indian Pharmacopoeia Commission (IPC) has taken a significant step toward strengthening public health systems with the draft release of the National Formulary of India (NFI) 2026, a comprehensive…

    Laser rescued an Imperiled Food Pipe in Sir Ganga Ram Hospital

    An Impacted Denture accidently  had lodged inside it New Delhi: In a remarkable medical achievement, doctors at Sir Ganga Ram Hospital successfully removed an impacted dental plate that had accidentally…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India